SCHEMBL6137730

SCHEMBL6137730

O=C1C=C(Br)C(=CNc2ccccc2)O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.42
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 2/20 0.40
NAMPT P43490 1/20 0.40
MAP1LC3B Q9GZQ8 1/20 0.36
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
KDM4E B2RXH2 3/20 0.32
RAB9A P51151 3/20 0.32
NPC1 O15118 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 3/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137729 1.00 ALDH1A1 (0.42) ALDH1A1HSP90AA1HSP90AB1SMN1; SMN2LMNA
SCHEMBL684330 1.00 ALDH1A1 (0.42) ALDH1A1HSP90AA1HSP90AB1SMN1; SMN2LMNA
SCHEMBL2166669 0.74 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2LMNAMAOAMAOB
SCHEMBL16628829 0.74 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2LMNAMAOAMAOB
SCHEMBL16628828 0.74 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2LMNAMAOAMAOB
SCHEMBL6336127 0.70 ALDH1A1 (0.46) ALDH1A1HSP90AA1HSP90AB1SMN1; SMN2LMNA
SCHEMBL6328556 0.70 PTPN1 (0.41) ALDH1A1HSP90AA1HSP90AB1SMN1; SMN2LMNA
SCHEMBL6138886 0.70 PTPN1 (0.41) ALDH1A1HSP90AA1HSP90AB1SMN1; SMN2LMNA
SCHEMBL1960493 0.68
SCHEMBL2166602 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050215772-A1 Furanone derivatives and methods of making same BIOSIGNAL LIMITED (AT) 2005-09-29 US disclosed
EP-1539692-A4 FURANONE DERIVATIVES AND METHODS OF MAKING SAME BIOSIGNAL LTD (AU) 2005-08-24 EP disclosed
EP-1539692-A1 FURANONE DERIVATIVES AND METHODS OF MAKING SAME Biosignal Limited (AU) 2005-06-15 EP disclosed
WO-2004016588-A1 FURANONE DERIVATIVES AND METHODS OF MAKING SAME BIOSIGNAL LIMITED (AU) 2004-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215772-A1 Furanone derivatives and methods of making same PFAS, CFAP20, FDPS ALDH1A1 1907/4885HSP90AA1 3122/4885HSP90AB1 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.